Source: BioPortfolio

Selexys Pharmaceuticals: Selexys Pharmaceuticals Corporation Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.MarketLines...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Scott Rollins's photo - President & CEO of Selexys Pharmaceuticals

President & CEO

Scott Rollins

CEO Approval Rating

88/100

Read more